PainReform Statistics
Total Valuation
PainReform has a market cap or net worth of $1.93 million. The enterprise value is -$1.49 million.
Important Dates
The last earnings date was Friday, November 14, 2025, after market close.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PainReform has 2.01 million shares outstanding. The number of shares has increased by 523.40% in one year.
| Current Share Class | 2.01M |
| Shares Outstanding | 2.01M |
| Shares Change (YoY) | +523.40% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.47% |
| Float | 1.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.23 |
| P/TBV Ratio | 1.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.59 |
| Quick Ratio | 1.52 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -127.65% and return on invested capital (ROIC) is -79.24%.
| Return on Equity (ROE) | -127.65% |
| Return on Assets (ROA) | -36.19% |
| Return on Invested Capital (ROIC) | -79.24% |
| Return on Capital Employed (ROCE) | -47.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$681,000 |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PainReform has paid $8,000 in taxes.
| Income Tax | 8,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.16% in the last 52 weeks. The beta is 0.56, so PainReform's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -64.16% |
| 50-Day Moving Average | 1.14 |
| 200-Day Moving Average | 1.73 |
| Relative Strength Index (RSI) | 46.03 |
| Average Volume (20 Days) | 142,091 |
Short Selling Information
The latest short interest is 204,790, so 10.17% of the outstanding shares have been sold short.
| Short Interest | 204,790 |
| Short Previous Month | 97,458 |
| Short % of Shares Out | 10.17% |
| Short % of Float | 11.16% |
| Short Ratio (days to cover) | 0.68 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.13M |
| Pretax Income | -4.08M |
| Net Income | -4.09M |
| EBITDA | -3.94M |
| EBIT | -4.13M |
| Earnings Per Share (EPS) | -$2.89 |
Full Income StatementBalance Sheet
The company has $3.48 million in cash and $56,000 in debt, giving a net cash position of $3.42 million or $1.70 per share.
| Cash & Cash Equivalents | 3.48M |
| Total Debt | 56,000 |
| Net Cash | 3.42M |
| Net Cash Per Share | $1.70 |
| Equity (Book Value) | 8.44M |
| Book Value Per Share | 4.19 |
| Working Capital | 1.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.96 million and capital expenditures -$1,000, giving a free cash flow of -$5.96 million.
| Operating Cash Flow | -5.96M |
| Capital Expenditures | -1,000 |
| Free Cash Flow | -5.96M |
| FCF Per Share | -$2.96 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
